Structured Summary
Abstract
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
6 entry terms
- Antiparkinson Drugs
- Antiparkinsonian Agents
- Antiparkinsonians
- Agents, Antiparkinson
- Agents, Antiparkinsonian
- Drugs, Antiparkinson
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
Indexing Annotation
general or unspecified; prefer specifics
MeSH Record
History Note
76; was ANTIPARKINSON DRUGS 1972-75 (Prov 1972); was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72
MeSH Record
Previous Indexing
- Parasympatholytics (1966-1972)
- Parkinsonism/drug therapy (1966-1972)
MeSH Hierarchy
Tree Number
MeSH Record
NLM Classification
QV 80
AMA Style
References
- National Library of Medicine. Antiparkinson Agents. Medical Subject Headings (MeSH). 2026. Unique ID D000978. http://id.nlm.nih.gov/mesh/2026/D000978
- Antiparkinson Agents. In: Wikipedia. https://en.wikipedia.org/wiki/Pharmacological_treatment_of_Parkinson%27s_disease
- Antiparkinson Agents. In: Wikidata. https://www.wikidata.org/wiki/Q3579672